NatWest Group’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-29,521
Closed -$6.28K 473
2014
Q4
$6.28K Sell
29,521
-1,672
-5% -$332K 0.05% 102
2014
Q3
$5.56K Sell
31,193
-17,385
-36% -$2.89M 0.05% 126
2014
Q2
$8.22M Sell
48,578
-35,392
-42% -$5.51M 0.35% 92
2014
Q1
$10.4M Sell
83,970
-22,529
-21% -$2.74M 0.46% 68
2013
Q4
$11.8M Buy
106,499
+6,565
+7% +$627K 0.3% 79
2013
Q3
$9.04M Buy
99,934
+15,175
+18% +$1.36M 0.26% 92
2013
Q2
$7.14M Buy
+84,759
New +$8.79M 0.1% 155

Other funds holding AGN

NatWest Group's AGN Position: Q1 2015 in Review

NatWest Group sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 29,521 shares — an estimated $6.28K sold.

NatWest Group first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $11.8M in Q4 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • NatWest Group reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • NatWest Group sold 29,521 Allergan Inc shares in Q1 2015, an estimated $6.28K.
  • NatWest Group first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • NatWest Group's Allergan Inc position peaked at $11.8M in Q4 2013.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on NatWest Group's 13F filing for Q1 2015, filed 14 May 2015.